Form 4: Lexaria Bioscience Director Catherine Turkel Reports Transaction in Company Stock
SEC Form 4
Director Catherine Turkel reports the disposition and acquisition of Lexaria Bioscience Corp. common shares and holdings of stock options.
Summary
- On August 12, 2024, Catherine C. Turkel, a director of Lexaria Bioscience Corp., reported a transaction involving the company's common shares.
- Turkel disposed of 1,500 common shares.
- Turkel acquired 1,600 common shares at a price of $3.13 per share.
- Following the reported transactions, Turkel directly owns 3,100 common shares.
- Turkel also holds derivative securities in the form of stock options with varying exercise prices and expiration dates, totaling 27,000 shares.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity, with no inherent positive or negative implications.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, like directors, who trade in their company's stock. It provides transparency to the market regarding the transactions of those with privileged information.
Key Dates
| Date | Description |
|---|---|
| 09/02/2022 | Date of exercisable stock options with an expiration date of 09/02/2027 and an exercise price of $3.04. |
| 10/12/2022 | Date of exercisable stock options with an expiration date of 10/12/2027 and an exercise price of $1.96. |
| 07/25/2023 | Date of exercisable stock options with an expiration date of 07/25/2028 and an exercise price of $0.87. |
| 04/26/2024 | Date of exercisable stock options with an expiration date of 04/26/2029 and an exercise price of $2.36. |
| 07/26/2024 | Date of exercisable stock options with an expiration date of 07/26/2029 and an exercise price of $3.39. |
| 08/12/2024 | Date of transaction where 1,500 common shares were disposed of and 1,600 common shares were acquired at $3.13. |
| 08/13/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.